Re: USA ZHCLF investors
in response to
by
posted on
Nov 04, 2022 12:05PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
So who issued the 63 m shares, ZCC or ZEL. Does ZCC issue the shares and give the money to ZEL or ZEL says "I need operating cash and am selling X number shares".